4//SEC Filing
Hughes Steven George 4
Accession 0001599901-25-000190
CIK 0001599901other
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 4:57 PM ET
Size
8.7 KB
Accession
0001599901-25-000190
Insider Transaction Report
Form 4
Hughes Steven George
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2025-09-22−2,208→ 70,667 totalExercise: $10.16Exp: 2034-01-19→ Common Stock (2,208 underlying) - Sale
Common Stock
2025-09-22$40.58/sh−2,208$89,601→ 38,867 total - Exercise/Conversion
Common Stock
2025-09-22$10.16/sh+2,208$22,433→ 41,075 total
Footnotes (2)
- [F1]The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.
- [F2]This option was granted on January 20, 2024 and vests in equal installments of 2,208 shares on each monthly anniversary of such grant date, until it is fully vested and exercisable on January 20, 2028.
Documents
Issuer
Avidity Biosciences, Inc.
CIK 0001599901
Entity typeother
Related Parties
1- filerCIK 0001747528
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 4:57 PM ET
- Size
- 8.7 KB